Gemmus Pharma Receives Series A Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d7ffcaf3-c702-48fa-a8cf-685dfb7cc8b1&Preview=1 -
Date
6/29/2012 -
Company Name
Gemmus Pharma -
Mailing Address
409 Illinois Street San Francisco, CA 94158 -
Company Description
Gemmus Pharma is a drug development company founded in 2007 to commercialize in-licensed technology from a major pharmaceutical company. Gemmus’ lead candidate is a cardiovascular drug currently marketed in Asia that has been repurposed for use as a treatment for influenza. -
Website
http://www.gemmuspharma.com -
Transaction Type
Venture Equity -
Transaction Amount
Undisclosed -
Transaction Round
Series A -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Life Science Angels -
Venture Investor
BlueTree Allied Angels -
Venture Investor
Tech Coast Angels -
Venture Investor
Wilmington Investor Network -
Venture Investor
The Angels’ Forum
